Clinical Trial Update: Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on Oxacom evaluating efficacy and safety in patients with pulmonary arterial hypertension in Phase 2/3. The trial is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Oxacom

Snippet

Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | Conditions: Pulmonary Arterial Hypertension | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING